Skip to main content

. 1993 Dec;46(12):1069–1070. doi: 10.1136/jcp.46.12.1069

Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology.

PMCID: PMC501711 PMID: 8282828

1069

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Haines A., Feder G. Guidance on guidelines. BMJ. 1992 Oct 3;305(6857):785–786. doi: 10.1136/bmj.305.6857.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991 Jun 27;324(26):1865–1875. doi: 10.1056/NEJM199106273242606. [DOI] [PubMed] [Google Scholar]
Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet. 1992 Oct 10;340(8824):873–876. [PubMed] [Google Scholar]
Saour J. N., Sieck J. O., Mamo L. A., Gallus A. S. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990 Feb 15;322(7):428–432. doi: 10.1056/NEJM199002153220703. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES